Eli Lilly CEO tells CNBC one-third of new GLP-1 pill patients are taking Foundayo, as drugmaker ramps up production
6 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
Velocity
How fast coverage is spreading — measured hourly from article rate × source diversity. How this works →
The brief
"Eli Lilly CEO tells CNBC one-third of new GLP-1 pill patients are taking Foundayo, as drugmaker ramps up production" is generating significant coverage in the Business category, with 6 articles from 6 distinct sources tracked by PULSE so far.
Outlets currently covering the story include Seeking Alpha, Healthcare Asia Magazine, Yahoo Finance and KSL News. PULSE measures a story's velocity from how quickly new articles appear and how many independent newsrooms join the coverage.
This brief was generated by PULSE's extractive engine from coverage metadata only. The latest headlines from every source are listed below; the velocity chart shows how the story is developing in real time.
Generated by PULSE's extractive engine from coverage metadata only — no AI-written claims. Updated 57d ago.
Quick answers
Why is "Eli Lilly CEO tells CNBC one-third of new GLP-1 pill patients are taking Founday" trending?
Because 6 independent news sources published 6 articles about it in a short window — a coverage burst PULSE classifies as a trend.
How does PULSE measure this trend?
PULSE scores velocity from the rate of new articles weighted by source diversity, snapshotted hourly. The full method is public on our methodology page.
Is this trend still active?
The status badge on this page updates hourly: rising, peaking, cooling, or archived once coverage stops for 48 hours.
Coverage (15)
- Eli Lilly breaks ground on $6.5B Houston plant Axios · 57d ago
- Lilly CEO Dave Ricks says Foundayo winning new pill patients Yahoo Finance · 57d ago
- The company behind a new GLP-1 pill is betting $6.5 billion on Houston Houston Chronicle · 57d ago
- Eli Lilly breaks ground on $6.5B Houston plant, largest project of its kind in Texas history The Business Journals · 57d ago
- Eli Lilly is breaking ground in Houston on a facility planned for 2030 KHOU · 57d ago
- Eli Lilly CEO Ricks sees more Foundayo growth with foreign markets TradingView · 57d ago
- Eli Lilly Stock (LLY) Rises After Company Provides Update on Obesity Pill Sales TipRanks · 57d ago
- Factbox-Weight-loss drug developers line up to tap lucrative market as competition heats up By Reuters Investing.com · 57d ago
- Lilly says Foundayo has captured over 30% of new US patients on oral weight-loss drugs Reuters · 57d ago
- Eli Lilly CEO Ricks sees more Foundayo growth with foreign markets Seeking Alpha · 57d ago
- Obesity drugs market to grow 27% across 7MM by 2036 Healthcare Asia Magazine · 57d ago
- Lilly’s Obesity Access Push via Medicare Bridge Might Change The Case For Investing In Eli Lilly (LLY) Yahoo Finance · 57d ago
- Factbox-Weight-loss drug developers line up to tap lucrative market as competition heats up KSL News · 57d ago
- Lilly's Foundayo pill wins over a third of new patients, CEO says qz.com · 57d ago
- Eli Lilly CEO tells CNBC one-third of new GLP-1 pill patients are taking Foundayo, as drugmaker ramps up production CNBC · 57d ago
Topics
Related trends
GLP-1 poison calls surge in Georgia as experts warn about unapproved weight-loss drugs - WSB-TV
Georgia poison centers report a surge in calls linked to GLP-1 weight-loss drugs as experts flag risks from unapproved versions.
Nvidia rejects Jensen Huang’s offer to return as CEO despite pressure from Silicon Valley
AP News reports Nvidia's board rejected founder Jensen Huang's offer to return as CEO despite Silicon Valley pressure.
Should you take GLP-1s during pregnancy? What some doctors say.
New research on GLP-1 drugs during pregnancy sparks urgent debate among doctors and patients.
Nvidia's Huang signals willingness to return as CEO; board creates national security panel
Jensen Huang says he would be honored to return as Nvidia CEO if the board asks, in his first statement since being unseated last week.
Home Depot names Richard McPhail as new CEO, beats earnings expectations
Home Depot appoints finance chief Richard McPhail as its new CEO while simultaneously reporting strong third-quarter earnings and sales beats.
Putin’s prized bridge is partially destroyed in Ukrainian strike
Ukraine damages Putin's Crimea bridge as Russia strikes vital Kyiv crossings in latest developments.